688617 惠泰医疗
已收盘 07-17 15:00:01
资讯
新帖
简况
惠泰医疗（688617）披露拟放弃控股子公司皓影医疗股权转让优先购买权，7月16日股价下跌1.41%
证券之星 · 07-16 17:22
惠泰医疗（688617）披露拟放弃控股子公司皓影医疗股权转让优先购买权，7月16日股价下跌1.41%
惠泰医疗（688617）披露关于控股子公司股权转让及公司放弃优先购买权暨关联交易的议案，7月8日股价上涨2.03%
证券之星 · 07-08
惠泰医疗（688617）披露关于控股子公司股权转让及公司放弃优先购买权暨关联交易的议案，7月8日股价上涨2.03%
惠泰医疗：目前公司生产经营情况正常
证券之星 · 06-29
惠泰医疗：目前公司生产经营情况正常
6月29日惠泰医疗涨5.43%，富国精准医疗混合A基金重仓该股
证券之星 · 06-29
6月29日惠泰医疗涨5.43%，富国精准医疗混合A基金重仓该股
惠泰医疗涨5.43%，国金证券二个月前给出“买入”评级
证券之星 · 06-29
惠泰医疗涨5.43%，国金证券二个月前给出“买入”评级
每周股票复盘：惠泰医疗（688617）维持全年PFA手术量目标
证券之星 · 06-14
每周股票复盘：惠泰医疗（688617）维持全年PFA手术量目标
惠泰医疗：6月5日接受机构调研，Capital Group Limited、Wellington Management Limited等多家机构参与
证券之星 · 06-10
惠泰医疗：6月5日接受机构调研，Capital Group Limited、Wellington Management Limited等多家机构参与
每周股票复盘：惠泰医疗（688617）董事会秘书完成培训正式履职
证券之星 · 06-07
每周股票复盘：惠泰医疗（688617）董事会秘书完成培训正式履职
惠泰医疗(688617.SH)子公司取得两项医疗器械注册证
智通财经 · 06-03
惠泰医疗(688617.SH)子公司取得两项医疗器械注册证
惠泰医疗（688617）披露2021年限制性股票激励计划第二个归属期归属结果暨股份上市公告，6月1日股价下跌0.49%
证券之星 · 06-01
惠泰医疗（688617）披露2021年限制性股票激励计划第二个归属期归属结果暨股份上市公告，6月1日股价下跌0.49%
每周股票复盘：惠泰医疗（688617）48.7万股归属6月3日上市
证券之星 · 05-31
每周股票复盘：惠泰医疗（688617）48.7万股归属6月3日上市
5月29日惠泰医疗创60日新低，富国精准医疗混合A基金重仓该股
证券之星 · 05-29
5月29日惠泰医疗创60日新低，富国精准医疗混合A基金重仓该股
每周股票复盘：惠泰医疗（688617）回购股份432,436股
证券之星 · 05-24
每周股票复盘：惠泰医疗（688617）回购股份432,436股
顶流基金经理最新动向出炉：张坤减持惠泰医疗，朱少醒、谢治宇调研这些股
澎湃新闻 · 05-20
顶流基金经理最新动向出炉：张坤减持惠泰医疗，朱少醒、谢治宇调研这些股
每周股票复盘：惠泰医疗（688617）董事长增持1.0万股并完成计划
证券之星 · 05-17
每周股票复盘：惠泰医疗（688617）董事长增持1.0万股并完成计划
惠泰医疗：5月14日董事长赵宇翔增持股份合计10000股
证券之星 · 05-14
惠泰医疗：5月14日董事长赵宇翔增持股份合计10000股
惠泰医疗（688617）披露以集中竞价交易方式回购股份的回购报告书，5月13日股价上涨2.71%
证券之星 · 05-13
惠泰医疗（688617）披露以集中竞价交易方式回购股份的回购报告书，5月13日股价上涨2.71%
每周股票复盘：惠泰医疗（688617）每股派现1元，股权登记日为5月13日
证券之星 · 05-10
每周股票复盘：惠泰医疗（688617）每股派现1元，股权登记日为5月13日
惠泰医疗（688617）披露2025年年度权益分派实施公告，5月7日股价上涨0.09%
证券之星 · 05-07
惠泰医疗（688617）披露2025年年度权益分派实施公告，5月7日股价上涨0.09%
每周股票复盘：惠泰医疗（688617）管理层调整聚焦营销赋能与研发协同
证券之星 · 05-02
每周股票复盘：惠泰医疗（688617）管理层调整聚焦营销赋能与研发协同
加载更多
公司概况
公司名称：
深圳惠泰医疗器械股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-01-07
主营业务：
深圳惠泰医疗器械股份有限公司的主营业务是心血管介入医疗器械的研发、生产和销售。公司的主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。
发行价格：
74.46
{"stockData":{"symbol":"688617","market":"SH","secType":"STK","nameCN":"惠泰医疗","latestPrice":204.18,"timestamp":1784271601000,"preClose":210,"halted":0,"volume":2047793,"delay":0,"changeRate":-0.0277,"floatShares":142000000,"shares":142000000,"eps":6.1255,"marketStatus":"已收盘","change":-5.82,"latestTime":"07-17 15:00:01","open":212.27,"high":212.27,"low":201.6,"amount":421000000,"amplitude":0.0508,"askPrice":205.38,"askSize":9,"bidPrice":204.18,"bidSize":2,"shortable":0,"etf":0,"ttmEps":6.1255,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":5,"adr":0,"adjPreClose":210,"symbolType":"stock_kcb","openAndCloseTimeList":[[1784251800000,1784259000000],[1784264400000,1784271600000]],"highLimit":231,"lowLimit":189,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":141529162,"isCdr":false,"pbRate":9.73,"roa":"--","peRate":33.332789,"roe":"7.54%","epsLYR":5.82,"committee":-0.542857,"marketValue":28897000000,"turnoverRate":0.0145,"status":1,"afterMarket":{"amount":0,"volume":0,"close":204.18,"buyVolume":700,"sellVolume":0,"time":1784273637746,"indexStatus":"已收盘 07-17 15:30:00","preClose":210},"floatMarketCap":28897000000},"requestUrl":"/m/hq/s/688617","defaultTab":"news","newsList":[{"id":"2651410297","title":"惠泰医疗（688617）披露拟放弃控股子公司皓影医疗股权转让优先购买权，7月16日股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651410297?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:22","pubTimestamp":1784193737,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，惠泰医疗报收于210.0元，较前一交易日下跌1.41%，最新总市值为297.21亿元。惠泰医疗于2026年7月16日披露《2026年第一次临时股东会会议资料》，拟放弃控股子公司皓影医疗的股权转让优先购买权，关联方成正辉将受让皓影医疗25%股权。皓影医疗2026年6月获第三类医疗器械注册证，公司基于战略发展考虑放弃优先购买权。交易后公司及惠泰中赛基金合计持股63.48%，仍为控股子公司，不影响合并范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600028154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649991093","title":"惠泰医疗（688617）披露关于控股子公司股权转让及公司放弃优先购买权暨关联交易的议案，7月8日股价上涨2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649991093","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649991093?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:15","pubTimestamp":1783520123,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，惠泰医疗报收于188.82元，较前一交易日上涨2.03%，最新总市值为267.24亿元。其中，《关于控股子公司股权转让及公司放弃优先购买权暨关联交易的议案》为本次股东会最受市场关注的事项之一，该议案对中小投资者单独计票，并涉及关联股东回避表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800042639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327566","title":"惠泰医疗：目前公司生产经营情况正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647327566?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:09","pubTimestamp":1782724147,"startTime":"0","endTime":"0","summary":"证券之星消息，惠泰医疗06月29日在投资者关系平台上答复投资者关心的问题。投资者提问：近期惠泰医疗股价持续调整，估值处于上市以来最低位，请问：1.当前公司生产经营是否正常，是否存在应披露未披露的重大事项？目前公司生产经营情况正常，不存在应披露而未披露的重大信息。公司计划于8月20日披露中报，二季度经营情况敬请关注，具体内容请以法定信息披露渠道发布的公告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900025585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647578322","title":"6月29日惠泰医疗涨5.43%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647578322","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647578322?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:46","pubTimestamp":1782722782,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日惠泰医疗涨5.43%，收盘报191.11元，换手率2.45%，成交量3.47万手，成交额6.56亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共58家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为31.86亿元，最新净值2.9889，较上一交易日下跌3.51%，近一年下跌3.06%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647683322","title":"惠泰医疗涨5.43%，国金证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647683322","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647683322?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:46","pubTimestamp":1782722769,"startTime":"0","endTime":"0","summary":"今日惠泰医疗涨5.43%，收盘报191.11元。2026年4月24日，国金证券研究员甘坛焕,何冠洲发布了对惠泰医疗的研报《业绩持续高增长，盈利能力稳健》，该研报对惠泰医疗给出“买入”评级。研报中预计公司2026-2028年归母净利润分别为10.01、12.38、15.56亿元，同比+22%、+24%、+26%，现价对应PE为35、28、22倍，维持“买入”评级。此外，太平洋研究员谭紫媚,李啸岩，华源证券研究员刘闯,林海霖近期也对该股发布了研报，同样给出“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643481217","title":"每周股票复盘：惠泰医疗（688617）维持全年PFA手术量目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2643481217","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643481217?lang=zh_cn&edition=full","pubTime":"2026-06-14 01:33","pubTimestamp":1781371990,"startTime":"0","endTime":"0","summary":"截至2026年6月12日收盘，惠泰医疗报收于205.0元，较上周的201.53元上涨1.72%。本周，惠泰医疗6月12日盘中最高价报205.87元。本周关注点来自机构调研要点：公司未调整全年PFA手术量目标及经营计划。中长期发展目标方面，惠泰致力于成长为全球领先的心血管器械企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061400000311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642414541","title":"惠泰医疗：6月5日接受机构调研，Capital Group Limited、Wellington Management Limited等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2642414541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642414541?lang=zh_cn&edition=full","pubTime":"2026-06-10 11:02","pubTimestamp":1781060540,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年6月9日惠泰医疗发布公告称公司于2026年6月5日接受机构调研，Capital Group Limited、Wellington Management Limited、Inforesight Investment Limited、富国基金管理有限公司、Janchor Partners Limited、阳光资产管理股份有限公司、Polunin Capital Partners Limited、Desjardins Global Asset Management Inc、Ren Bridge Fund、FSSA Investment Managers、Temasek Holdings Pte Ltd、GIC Private Limited、UBS、Greenwoods Asset Management参与。迈瑞并购后，公司经营管理出现多项积极变化，整体符合预期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000015392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641279921","title":"每周股票复盘：惠泰医疗（688617）董事会秘书完成培训正式履职","url":"https://stock-news.laohu8.com/highlight/detail?id=2641279921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641279921?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:36","pubTimestamp":1780770972,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，惠泰医疗报收于201.53元，较上周的205.59元下跌1.97%。本周，惠泰医疗6月2日盘中最高价报209.5元。6月4日盘中最低价报198.0元，股价触及近一年最低点。惠泰医疗当前最新总市值285.22亿元，在医疗器械板块市值排名7/129，在两市A股市值排名742/5206。本周关注点公司公告汇总：董事会秘书黄星星先生完成培训并取得任职证明，正式履职。自取得证明并获审核无异议之日起，黄星星先生正式履行董事会秘书职责，赵宇翔先生不再代行该职务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640742906","title":"惠泰医疗(688617.SH)子公司取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2640742906","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640742906?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:02","pubTimestamp":1780484555,"startTime":"0","endTime":"0","summary":"智通财经APP讯，惠泰医疗(688617.SH)发布公告，近日，公司控股子公司深圳皓影医疗科技有限公司取得两项医疗器械注册证，产品分别为血管内超声诊断设备与一次性使用血管内超声诊断导管。上述医疗器械注册证的取得，有利于丰富公司的产品种类，扩充公司在冠脉介入影像领域的产品布局，不断满足多元化的临床需求，进一步增强公司的核心竞争能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1574","159883","BK0251","688617","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640930240","title":"惠泰医疗（688617）披露2021年限制性股票激励计划第二个归属期归属结果暨股份上市公告，6月1日股价下跌0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640930240","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640930240?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:50","pubTimestamp":1780307421,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，惠泰医疗报收于204.58元，较前一交易日下跌0.49%，最新总市值为289.54亿元。该股当日开盘205.58元，最高209.39元，最低201.43元，成交额达3.93亿元，换手率为1.35%。公告显示，公司已完成2021年限制性股票激励计划首次授予及预留部分授予A类限制性股票第二个归属期的股份登记，归属股票数量为487,383股，上市流通日期为2026年6月3日。公司总股本由141,041,779股增至141,529,162股，控股股东及实际控制人未发生变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100027562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639604138","title":"每周股票复盘：惠泰医疗（688617）48.7万股归属6月3日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2639604138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639604138?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:33","pubTimestamp":1780169590,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，惠泰医疗报收于205.59元，较上周的217.2元下跌5.35%。本周，惠泰医疗5月26日盘中最高价报226.56元。公司公告汇总深圳惠泰医疗器械股份有限公司完成了2021年限制性股票激励计划首次授予及预留部分授予A类限制性股票第二个归属期的股份登记，归属股票数量为487,383股，上市流通日期为2026年6月3日。公司总股本由141,041,779股增至141,529,162股，控股股东及实际控制人未发生变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639289726","title":"5月29日惠泰医疗创60日新低，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639289726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639289726?lang=zh_cn&edition=full","pubTime":"2026-05-29 16:43","pubTimestamp":1780044188,"startTime":"0","endTime":"0","summary":"证券之星消息，5月29日惠泰医疗创60日新低，收盘报205.59元，当日跌2.37%，换手率1.03%，成交量1.45万手，成交额3.03亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共58家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为31.86亿元，最新净值2.9615，较上一交易日下跌2.11%，近一年上涨3.52%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900030362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637757203","title":"每周股票复盘：惠泰医疗（688617）回购股份432,436股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637757203","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637757203?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:22","pubTimestamp":1779567732,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，惠泰医疗报收于217.2元，较上周的234.21元下跌7.26%。本周，惠泰医疗5月18日盘中最高价报234.55元。本周关注点公司公告汇总：惠泰医疗已累计回购股份432,436股，占公司总股本的0.3066%。截至2026年5月21日，公司已累计回购股份432,436股，占公司总股本的0.3066%，实际支付金额9,998.3393万元，回购价格区间为223.00元/股至236.09元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636898218","title":"顶流基金经理最新动向出炉：张坤减持惠泰医疗，朱少醒、谢治宇调研这些股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636898218","media":"澎湃新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636898218?lang=zh_cn&edition=full","pubTime":"2026-05-20 07:24","pubTimestamp":1779233040,"startTime":"0","endTime":"0","summary":"多位知名基金经理最新调仓路径与调研动向出炉。具体来看，易方达张坤管理的易方达蓝筹精选，在二季度期间小幅减持高新技术企业惠泰医疗，而对五粮液（维权）的持仓则按兵不动；工银瑞信杨鑫鑫管理的工银创新动力，也对手中的重仓股玲珑轮胎进行了微调。值得一提的是，朱少醒、谢治宇、乔迁、史博等多位百亿基金经理也频频现身调研名单，释放布局信号。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-05-20/doc-inhynvwt1812081.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-05-20/doc-inhynvwt1812081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636629061","title":"每周股票复盘：惠泰医疗（688617）董事长增持1.0万股并完成计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2636629061","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636629061?lang=zh_cn&edition=full","pubTime":"2026-05-17 02:00","pubTimestamp":1778954432,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，惠泰医疗报收于234.21元，较上周的232.61元上涨0.69%。本周，惠泰医疗5月13日盘中最高价报242.79元。来自公司公告汇总：调整2021年限制性股票激励计划授予价格，并确认第二期归属条件符合。股本股东变化高管增减持2026年5月14日，惠泰医疗董事长赵宇翔增持公司股份1.0万股，占总股本0.0071%。回购股份将用于员工持股计划或股权激励；若三年内未转让完毕，未转让股份将依法注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635743248","title":"惠泰医疗：5月14日董事长赵宇翔增持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635743248","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635743248?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:01","pubTimestamp":1778767292,"startTime":"0","endTime":"0","summary":"证券之星消息，根据5月14日市场公开信息、上市公司公告及交易所披露数据整理，惠泰医疗最新董监高及相关人员股份变动情况：2026年5月14日公司董事长赵宇翔共增持公司股份1.0万股，占公司总股本为0.0071%。惠泰医疗近半年内的董监高及核心技术人员增减持详情如下：惠泰医疗的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入984.96万，融资余额增加；融券净流出797.0，融券余额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400042620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635200676","title":"惠泰医疗（688617）披露以集中竞价交易方式回购股份的回购报告书，5月13日股价上涨2.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635200676","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635200676?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:50","pubTimestamp":1778665804,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，惠泰医疗报收于241.98元，较前一交易日上涨2.71%，最新总市值为341.29亿元。公司于2026年5月13日披露《关于以集中竞价交易方式回购股份的回购报告书》。公告显示，深圳惠泰医疗器械股份有限公司计划以集中竞价交易方式回购股份，回购资金总额不低于5000万元且不超过10000万元，资金来源为自有资金。相关股东在回购决议日前后无明确减持计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300033033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634411037","title":"每周股票复盘：惠泰医疗（688617）每股派现1元，股权登记日为5月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2634411037","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634411037?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:01","pubTimestamp":1778349671,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，惠泰医疗报收于232.61元，较上周的237.87元下跌2.21%。本周，惠泰医疗5月6日盘中最高价报237.92元。本周关注点公司公告汇总：惠泰医疗2025年年度权益分派实施，每股现金红利1元（含税），股权登记日为2026年5月13日。截至申请日，公司总股本为141,041,779股，回购专户持有1,869,440股，实际参与分配股份数为139,172,339股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126419","title":"惠泰医疗（688617）披露2025年年度权益分派实施公告，5月7日股价上涨0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126419","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633126419?lang=zh_cn&edition=full","pubTime":"2026-05-07 22:53","pubTimestamp":1778165592,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，惠泰医疗报收于234.6元，较前一交易日上涨0.09%，最新总市值为330.88亿元。该股当日开盘235.77元，最高235.77元，最低230.61元，成交额达1.91亿元，换手率为0.58%。近日，惠泰医疗发布《2025年年度权益分派实施公告》。股权登记日为2026年5月13日，除权（息）日和现金红利发放日均为2026年5月14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700041680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632764734","title":"每周股票复盘：惠泰医疗（688617）管理层调整聚焦营销赋能与研发协同","url":"https://stock-news.laohu8.com/highlight/detail?id=2632764734","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632764734?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:13","pubTimestamp":1777666388,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，惠泰医疗报收于237.87元，较上周的248.0元下跌4.08%。本周，惠泰医疗4月28日盘中最高价报251.74元。答：本次管理层的调整，属于迈瑞对惠泰进行整合协同过程中的正常人员调整；公司2024年4月正式并入迈瑞集团，在过去两年，整合协同的重点聚焦于研发领域，尤其是电生理的研发。为了更好适配公司现阶段业务发展的需要，公司进行了本次管理层调整。本次人员调整，是迈瑞与公司核心管理层充分商议、达成高度一致的结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784274192451,"stockEarnings":[{"period":"1week","weight":0.0641},{"period":"1month","weight":0.072},{"period":"3month","weight":-0.1764},{"period":"6month","weight":-0.1626},{"period":"1year","weight":-0.2781},{"period":"ytd","weight":-0.1332}],"compareEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.0512},{"period":"3month","weight":-0.0417},{"period":"6month","weight":-0.0535},{"period":"1year","weight":0.1081},{"period":"ytd","weight":-0.0218}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳惠泰医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6525人(较上一季度增加8.21%)","perCapita":"21690股","listingDate":"2021-01-07","address":"广东省深圳市南山区西丽街道松坪山社区松坪山朗山路11号同方信息港B栋601","registeredCapital":"14152万元","survey":" 深圳惠泰医疗器械股份有限公司的主营业务是心血管介入医疗器械的研发、生产和销售。公司的主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。","listedPrice":74.46},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"惠泰医疗,688617,惠泰医疗股票,惠泰医疗股票老虎,惠泰医疗股票老虎国际,惠泰医疗行情,惠泰医疗股票行情,惠泰医疗股价,惠泰医疗股市,惠泰医疗股票价格,惠泰医疗股票交易,惠泰医疗股票购买,惠泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}